June 2019 newsletter
Therapeutic protein degradation by design; Presentations from recent meetings; Review of Efficient Drug Discovery Through Connected Chemistry symposium; New website
In this case study, Giovanna Tedesco, used Activity Atlas to analyze the SAR of a large data set of Orexin-2 receptor ligands taken from the patent literature to rapidly investigate and understand the electrostatic, hydrophobic and shape features of each recently published scaffold.
We are released two new webclips on features of our software:
As graphics cards and CPUs have become faster since the release of BlazeGPU, Dr Mark Mackey looks at how the new hardware performs.
What type of tasks and projects do we work on? Dr Martin Slater explains.
This case study describes how Re-Pharm scientists used Forge, Cresset’s computational chemistry suite for understanding SAR and design, to find an active compound that Re-Pharm has patented as a novel anti-inflammatory agent with ‘steroid sparing’ capability.
Scientific program plus software tips and tricks.
Find out more and register free.
16 June: Scientific program featuring presentations on Cresset software and Discovery Services plus: Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, University of Hertfordshire, more to be confirmed.
17 June: Workshops and clinics.
Find out more. Registration will open in February.